Hepatitis C Virus Infection in Non-Hodgkin’s Lymphoma: A Case-Control Study
| Author | SHAIKH MUHAMMAD | en |
| Author | Mujahid Ali Chandio | en |
| Author | Muhammad Soomro | en |
| Author | Bashir Ahmaed Shaikh | en |
| Issued Date | 2012-01-31 | en |
| Abstract | Background: Hepatitis C virus (HCV) is the most common cause of chronic liver disease in Pakistan [1]. Globally, an estimated 170 million people are infected with HCV, with approximately 3-4 million new cases each year [2][3]. Currently, the prevalence of HCV in Pakistan is 4-7% [4][5][6]. HCV is a hepatotropic virus that causes chronic hepatitis in at least 80% of infected individuals. If untreated, 20-30% of the cases will eventually develop cirrhosis, with average latency of 15-25 years, and hepatocellular carcinoma, at the rate of 1-5% per year and average latency of 20-30 years [3][7]. | en |
| DOI | https://doi.org/10.5812/kowsar.1735143X.801 | en |
| Keyword | Hepatitis C | en |
| Keyword | Hepatitis C Antibodies | en |
| Keyword | Association | en |
| Keyword | Non-Hodgkin's Lymphoma | en |
| Publisher | Brieflands | en |
| Title | Hepatitis C Virus Infection in Non-Hodgkin’s Lymphoma: A Case-Control Study | en |
| Type | Research Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Hepatitis_C_Virus_Infection_in_Non-Hodgk.pdf
- Size:
- 309.62 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF